Literature DB >> 8396630

Isobolographic superadditivity between delta and mu opioid agonists in the rat depends on the ratio of compounds, the mu agonist and the analgesic assay used.

J U Adams1, R J Tallarida, E B Geller, M W Adler.   

Abstract

The present study was designed to test rigorously, using isobolographic analysis, whether there was a potentiative interaction between delta and mu agonists administered i.c.v. to rats. Factors such as the specific fixed ratio of compounds, the analgesic assay and the mu agonist were varied to determine the generality of the results. Male rats were implanted with i.c.v. cannulas and were tested in the cold (-3 degrees C) or hot (+50 degrees C) water tail-flick test. Full dose-effect curves were generated for the mu agonists, morphine and [N-MePhe3,D-Pro4]morphiceptin and the delta-selective agonist, DPDPE. Each agonist induced dose-related analgesia in the cold water test (ED50 values were 12, 0.79 and 75 micrograms, respectively). In the hot water test, morphine induced analgesia with an ED50 value of 4.4 micrograms, whereas DPDPE failed to produce a full effect at doses up to 200 micrograms. Full dose-effect curves were also generated for various fixed-ratio combinations of DPDPE and morphine in both analgesic assays. Fixed ratios were chosen such that the amount of DPDPE in each dose of the combinations tested was itself subanalgesic. The combination with 20% DPDPE and 80% morphine (by weight) was significantly superadditive in the cold water test as determined by isobolographic analysis, whereas a second combination of the same drugs (40% DPDPE) was not. However, in the hot water test, the 20% DPDPE combination was not superadditive and neither were two other combinations of DPDPE and morphine. No combination of DPDPE and [N-MePhe3,D-Pro4]morphiceplin differed significantly from additivity when tested in the cold water test.(ABSTRACT TRUNCATED AT 250 WORDS)

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8396630

Source DB:  PubMed          Journal:  J Pharmacol Exp Ther        ISSN: 0022-3565            Impact factor:   4.030


  17 in total

1.  The analgesic effects of supraspinal mu and delta opioid receptor agonists are potentiated during persistent inflammation.

Authors:  R W Hurley; D L Hammond
Journal:  J Neurosci       Date:  2000-02-01       Impact factor: 6.167

Review 2.  Revisiting the isobole and related quantitative methods for assessing drug synergism.

Authors:  Ronald J Tallarida
Journal:  J Pharmacol Exp Ther       Date:  2012-04-17       Impact factor: 4.030

3.  Quantitative methods for assessing drug synergism.

Authors:  Ronald J Tallarida
Journal:  Genes Cancer       Date:  2011-11

4.  Co-administration of δ- and μ-opioid receptor agonists promotes peripheral opioid receptor function.

Authors:  Cicely L Schramm; Christopher N Honda
Journal:  Pain       Date:  2010-12       Impact factor: 6.961

Review 5.  Pharmacotherapy of opioids: present and future developments.

Authors:  T F Meert
Journal:  Pharm World Sci       Date:  1996-01

6.  Selective enhancement of fentanyl-induced antinociception by the delta agonist SNC162 but not by ketamine in rhesus monkeys: Further evidence supportive of delta agonists as candidate adjuncts to mu opioid analgesics.

Authors:  Matthew L Banks; John E Folk; Kenner C Rice; S Stevens Negus
Journal:  Pharmacol Biochem Behav       Date:  2010-08-03       Impact factor: 3.533

7.  Synaptic mechanism for functional synergism between delta- and mu-opioid receptors.

Authors:  Zhi Zhang; Zhizhong Z Pan
Journal:  J Neurosci       Date:  2010-03-31       Impact factor: 6.167

8.  Delta/mu opioid receptor interactions in operant conditioning assays of pain-depressed responding and drug-induced rate suppression: assessment of therapeutic index in male Sprague Dawley rats.

Authors:  Katherine Cone; Janell Lanpher; Abigail Kinens; Philomena Richard; Sarah Couture; Rebecca Brackin; Emily Payne; Kylee Harrington; Kenner C Rice; Glenn W Stevenson
Journal:  Psychopharmacology (Berl)       Date:  2018-03-23       Impact factor: 4.530

9.  Effects of the delta-opioid agonist SNC80 on the abuse liability of methadone in rhesus monkeys: a behavioral economic analysis.

Authors:  Matthew L Banks; Peter G Roma; John E Folk; Kenner C Rice; S Stevens Negus
Journal:  Psychopharmacology (Berl)       Date:  2011-03-03       Impact factor: 4.530

10.  An isobolographic analysis of the effects of N-methyl-D-aspartate and NK1 tachykinin receptor antagonists on inflammatory hyperalgesia in the rat.

Authors:  K Ren; M J Iadarola; R Dubner
Journal:  Br J Pharmacol       Date:  1996-01       Impact factor: 8.739

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.